Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

Benzinga · 1d ago
Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.